Choukroun G, Itakura Y, Albouze G, Christophe J L, Man N K, Grünfeld J P, Jungers P
Department of Nephrology, Necker Hospital, Paris, France.
J Am Soc Nephrol. 1995 Dec;6(6):1634-42. doi: 10.1681/ASN.V661634.
Autosomal dominant polycystic kidney disease (ADPKD) frequently leads to end-stage renal failure (ESRF) in the sixth decade of life, but considerable heterogeneity exists in the rate of progression of renal failure. The respective contribution of genetic factors and of potentially amendable factors, such as blood pressure control or protein intake limitation, on the rate of progression in ADPKD patients is still debated. To evaluate the role of factors influencing the rate of progression of renal failure in ADPKD, we retrospectively analyzed the annual rate of decline of creatinine clearance (Ccr) in 109 ADPKD patients followed from the time a Ccr value of 30 to 50 mL per min/1.73 m2 was measured until ESRD and need for hemodialysis (Study A), and in 48 undialyzed ADPKD patients followed for at least 4 yr from the time a Ccr value of 50 to 60 mL per min/1.73 m2 was measured (Study B). In Study A, the decline in Ccr (delta Ccr) (mean +/- SE) was 5.8 +/- 0.2 mL per min/1.73 m2 per year in the whole series, and was lower in females than in males (5.0 +/- 0.2 versus 6.4 +/- 0.2, P < 0.001). Accordingly, ESRF was reached at a later age in female patients (55.1 +/- 1.2 versus 50.6 +/- 1.2 yr, P < 0.01). The age at ESRF in male patients was lower when the disease was transmitted by mother than by father (46.3 +/- 1.9 versus 54.1 +/- 1.8 yr, P < 0.01), whereas no significant effect of the gender of the affected parent was apparent in female patients. By regression analysis, there was a positive but weak relationship between delta Ccr and mean arterial pressure (average value during follow-up, 107 +/- 1 mm Hg, r = 0.224, P < 0.05) but not with dietary protein intake (mean value in follow-up, 0.87 +/- 0.03 g/kg per day, r = 0.10, P = 0.33) nor with proteinuria at baseline, which was lower than 0.3 g/day in 104 cases (r = 0.10, P = 0.28). There was a negative relationship between age at ESRF and delta Ccr (r = 0.245, P < 0.05), with a later and slower progression in older subjects. In Study B, the mean decline in renal function during follow-up was 5.3 +/- 0.4 mL/min/1.73 m2 per year, a value close to that observed in Study A. By multiple regression analysis of the overall population (studies A and B combined), only MAP, age and gender were independent predictive factors of delta Ccr but all studied parameters taken together accounted for at best 20% of delta Ccr variation. We conclude that the rate of progression of renal failure in ADPKD patients is mainly determined by gene expression, with female gender and older age associated with a slower progression, whereas blood pressure control, but not protein intake, exerts a limited beneficial influence on the rate of progression in patients with advanced polycystic kidney disease who already have significant renal insufficiency.
常染色体显性多囊肾病(ADPKD)在患者60岁左右时常常会发展为终末期肾衰竭(ESRF),但肾衰竭的进展速度存在很大的异质性。基因因素以及一些可能可调节的因素,如血压控制或蛋白质摄入量限制,对ADPKD患者肾衰竭进展速度的各自影响仍存在争议。为了评估影响ADPKD患者肾衰竭进展速度的因素的作用,我们回顾性分析了109例ADPKD患者的肌酐清除率(Ccr)年下降率。这些患者从测得Ccr值为每分钟30至50毫升/1.73平方米开始随访,直至发展为ESRF并需要进行血液透析(研究A);还分析了48例未接受透析的ADPKD患者的情况,这些患者从测得Ccr值为每分钟50至60毫升/1.73平方米开始至少随访4年(研究B)。在研究A中,整个队列的Ccr下降值(ΔCcr)(均值±标准误)为每年5.8±每分钟0.2毫升/1.73平方米,女性低于男性(5.0±0.2对6.4±0.2,P<0.001)。因此,女性患者达到ESRF的年龄较晚(55.1±1.2对50.6±1.2岁,P<0.01)。男性患者中,疾病由母亲遗传时达到ESRF的年龄低于由父亲遗传时(46.3±1.9对54.1±1.8岁,P<0.01),而在女性患者中,患病父母的性别没有明显影响。通过回归分析,ΔCcr与平均动脉压之间存在正相关但较弱的关系(随访期间平均值为107±1毫米汞柱,r = 0.224,P<0.05),但与饮食蛋白质摄入量(随访期间平均值为每天0.8±0.03克/千克,r = 0.10,P = 0.33)以及基线蛋白尿无关,104例患者的基线蛋白尿低于每天0.3克(r = 0.10,P = 0.28)。达到ESRF的年龄与ΔCcr之间存在负相关(r = 0.245,P<0.05),年龄较大的患者进展较晚且较慢。在研究B中,随访期间肾功能平均下降值为每年5.3±0.4毫升/分钟/1.73平方米,与研究A中观察到的值相近。通过对总体人群(研究A和B合并)进行多元回归分析,只有平均动脉压(MAP)、年龄和性别是ΔCcr的独立预测因素,但所有研究参数综合起来最多只能解释ΔCcr变化的20%。我们得出结论,ADPKD患者肾衰竭的进展速度主要由基因表达决定,女性和年龄较大与进展较慢相关,而血压控制(而非蛋白质摄入量)对已经有明显肾功能不全的晚期多囊肾病患者的进展速度有有限的有益影响。